Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
-
chemicals the full details Concurrent with the clinical eval
2019-05-13
Concurrent with the clinical evaluation of the family, the genetic findings from a molecular autopsy may help to elucidate the cause of death in the decedent, as well as provide a basis for cascade genetic testing of at-risk family members. Offering cascade genetic testing to asymptomatic relatives
-
The aim of this cross sectional
2019-05-13
The aim of this cross-sectional study was to investigate the relationships between patient characteristics and antithrombotic therapy prescribed for the prevention of ischemic stroke and systemic embolism in patients with NVAF in clinical practice. Additionally, because the data were to be used to c
-
In an earlier study we used a
2019-05-13
In an earlier study, we used a questionnaire to assess musculoskeletal pain in patients with CML who had achieved DMR (MR4.0) and discontinued TKI treatment, including IM, nilotinib, and dasatinib [5]. Nine out of the 27 patients surveyed developed musculoskeletal pain after discontinuing TKIs. In t
-
India s National Programme for Prevention and Control
2019-05-13
India\'s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke is an important step to integrate preventative and treatment interventions within the National Health Mission Framework. Reliable, direct monitoring of cause-specific mortality in India is s
-
The circadian variation of VF shows a
2019-05-10
The circadian variation of VF shows a similar nocturnal pattern in patients with BS and ERS [32] (Fig. 2). This is in contrast to the circadian pattern of VTAs in patients with ischemic heart diseases [33]. In a Korean cohort of patients with ERS and BS who underwent implantable cardioverter defibr
-
After exclusion of secondary causes of
2019-05-10
After exclusion of secondary causes of eosinophilia, diagnostic evaluation of primary eosinophilias relies on a combination of morphologic review of the blood and marrow, standard cytogenetics, fluorescent in situ hybridization, flow immunocytometry, and T-cell clonality assessment to detect histopa
-
h2 receptor antagonist Causative genes for ARVC and their re
2019-05-10
Causative genes for ARVC and their respective characteristics are summarized in Table 1. Desmosome genes for ARVC Other causative genes for ARVC Although more than half of ARVC patients carry mutations in desmosome genes, other genes have also been reported as causative genes for ARVC (Table
-
Confrontaremos los datos que la hemerograf a nos ofrece
2019-05-10
Confrontaremos los datos que la hemerografía nos ofrece y las fuentes orales que han permitido la reconstrucción y el conocimiento de la experiencia del -. A partir de ello, queremos contribuir en el discernimiento y reconstrucción del conflicto, el cual, hematoxylin 20 años de la firma de los Acuer
-
br Results and discussion br
2019-05-10
Results and discussion Authorship contributions Conflict of interest Acknowledgments This work is supported by grants from the United States National Institutes of Health/National Cancer Institute: R01 CA098472 and R01 CA170334. We thank Dr. Dan Zhang and Andy Awwad for technical assista
-
Apart from their association with
2019-05-09
Apart from their association with severe pain and reduced quality of life, SREs require substantial healthcare resource utilization (HRU) in their treatment and management. Previous retrospective studies have attempted to quantify various aspects of the burden of SREs across specific tumor types/cou
-
As shown in Fig out of the patients who
2019-05-09
As shown in Fig. 2, 40 out of the 60 patients (66.6%) who developed amiodarone-induced hypothyroidism, and 10 out of the 30 patients (33.3%) who developed amiodarone-induced hyperthyroidism, were diagnosed within two years of kras-pdeδ pathway of amiodarone therapy. Amiodarone-induced hypothyroidis
-
To raise awareness of the importance of birth
2019-05-09
To raise awareness of the importance of birth registration and to discuss strategies to promote it, UNICEF is launching two related publications on the anniversary of the organisation\'s founding is a statistical analysis spanning 161 countries and presenting the latest available country data and es
-
Pyrrolidinedithiocarbamate ammonium Romiplostim is an Fc fus
2019-05-09
Romiplostim is an Fc-fusion protein that augments thrombopoiesis by binding to and activating the thrombopoietin receptor. It is approved for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglo
-
This patient s shortest R R interval on
2019-05-09
This patient\'s shortest R–R interval on ECG was about 200ms (300bpm), which indicated high risk of sudden cardiac death. The patient underwent catheter ablation. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias [1], which include accessory pathway-mediated arr
-
The risk of breast cancer
2019-05-09
The risk of breast cancer development in men with Klinefelter syndrome is 20 times that in men without the syndrome. Gynecomastia occurs after puberty in about 85% of male patients with Klinefelter syndrome. These conditions are related to hormonal imbalance with low plasma testosterone and high est
15577 records 1004/1039 page Previous Next First page 上5页 10011002100310041005 下5页 Last page